Vaccination With Autologous, Lethally Irradiated Melanoma Cells Engineered by Adenoviral Mediated Gene Transfer to Secrete Granulocyte-Macrophage Stimulating Factor (GMSF)
Clinical trial NCT00809588 · COMPLETED
Trial details
- NCT number
- NCT00809588
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2003-10-16
- Primary completion
- 2016-09-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.